Biotech
Idorsia Pharmaceuticals Ltd.
1
Articles
Deal Party
Top Role
Apr 11, 2026
First Mention
Apr 11, 2026
Last Mention
1.55
Relevance Score
Coverage Timeline
April 2026
Sanofi’s $1.8B Insomnia Bet: What the Idorsia Deal Says About Sleep Drugs and Biopharma Valuation
Deals
Deal Party
Apr 11, 2026
Sanofi’s rationale centers on the sleep disorder market, a vast, chronically under-treated area where generics like zolpidem dominate.